F4 FundFund
TeamPortfolioRaiseChampionsEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investorsSimilar Firms
Warm Fund

Wireframe Ventures

www.wireframevc.com · San Francisco, California

“Extraordinary companies are built by driven founders whose mission to improve the health of people and planet is inseparable from their product. We partner with technical founders building technology solutions to the world's most important challenges across climate, health, biotech, and enabling technologies.”

$500K – $2M
Check Size
Leads
Lead Tendency
$77M
AUM
~2 Weeks
Timeline
01Investment Thesis

Extraordinary companies are built by driven founders whose mission to improve the health of people and planet is inseparable from their product. We partner with technical founders building technology solutions to the world's most important challenges across climate, health, biotech, and enabling technologies.

Exclusion Criteria

Founders without genuine mission alignment, pure social impact without proven business models, non-technical founders in hard-tech sectors, founders seeking passive capital without partnership approach

02Investment Team
HP
Harsh Patel
Managing Partner & Co-Founder
PS
Paul Straub
Managing Partner & Co-Founder
LB
Lily Bernicker
Partner
03F4 Research Brief

Wireframe Ventures Research

Investment Thesis

Wireframe Ventures is a pre-seed and seed-stage venture capital firm dedicated to backing extraordinary founders on a mission to improve the health of people and the planet. Founded in 2016 by Paul Straub and Harsh Patel, Wireframe believes that the best companies are built by driven founders whose mission is core to their product—a "people-product-purpose" thesis. The firm combines a post-Cleantech 1.0 perspective with domain expertise across climate, biotech, healthcare, and enabling technologies, providing hands-on support from day one.

Investment Focus

Wireframe invests across five primary impact themes:

Climate & Clean Energy: Founders deploying technology to address climate change, including renewable energy platforms, carbon sequestration, sustainable materials, and circular economy solutions.

Healthcare & Life Sciences: Companies delivering healthcare that is personal and proactive, including biotech, diagnostics, therapeutics, precision medicine, and healthcare IT solutions.

Biology & Bio-Engineering: Using biological systems to engineer better products, including synthetic biology, CRISPR applications, biomaterials, and bioremediation.

AI & Automation: Deploying AI and automation to empower humans, including intelligent systems, automation infrastructure, and decision-support tools.

Sustainable Transportation & Logistics: Technology enabling safe, zero-carbon transportation and efficient supply chains.

Investment Approach

Wireframe is a first-check investor that leads or joins high-quality syndicates at pre-seed and seed stages. The firm typically invests $500K-$2M in initial rounds, backing companies pre-revenue and even pre-product if the founder has compelling articulation of their business. Wireframe maintains a hands-on approach post-investment, with Managing Partners intensely focused on supporting founding teams toward product-market fit and institutional Series A funding.

The firm's founders bring significant operating experience. Harsh Patel studied at Stanford Graduate School of Business and combines founder and CTO background with deep domain expertise. Paul Straub, educated at Duke Fuqua and University of Virginia, brings experience from the first cleantech boom and applies those lessons to current climate tech investment. Lily Bernicker, promoted to Partner in November 2024, adds additional sector expertise.

Fund Details

Wireframe I launched in 2016. Wireframe II, a $77M pre-seed and seed fund, closed in April 2022 and is currently actively deploying capital. The firm targets 15-20% ownership in seed-stage companies and 15-20% ownership in Series A follow-ons.

Portfolio Overview & Performance

Wireframe has made 70+ investments across 33 portfolio companies, with exceptional performance metrics:

  • 71% of portfolio companies raised follow-on institutional funding within 15 months of Wireframe's investment
  • 67% started by first-time founders, demonstrating the firm's ability to back inexperienced but mission-driven teams
  • 38% have female or underrepresented minority founders, reflecting a strong commitment to diversity
  • Two portfolio unicorns: Enveda Biosciences (now worth $1B+) and Palantir (NYSE: PLTR)
  • Notable exits: OpenInvest (acquired by JPMorgan Chase), Electriphi (acquired by Ford), Assurex Health/GeneSight (acquired by Myriad Genetics)

Recent Notable Investments

Active Deployments (2024-2025):

  • Enveda Biosciences: Pre-seed (Sept 2019), Series A, Series B (2023), Series D ($150M, Sept 2025) - Applying AI to discover nature-derived medicines, achieved unicorn status
  • Mammoth Biosciences: Seed (Jan 2018) - CRISPR systems developer, cofounded by Nobel Prize winner Jennifer Doudna
  • Xcimer Energy: Seed (Oct 2022) - Building laser-driven nuclear fusion systems, awarded DOE grant in 2023
  • LevelTen Energy: Series A (Sept 2017) - Corporate renewable energy procurement platform, raised $65M (2024) with Microsoft and Google
  • Mycoworks: Series A (May 2019) - Bioengineered sustainable leather alternatives
  • Near Space Labs: Seed (June 2018) - High-resolution persistent earth imaging
  • SPAN.io: Seed (Dec 2018) - Smart electrical panels for home energy management
  • Recurrent Auto: Seed (Nov 2020) - Battery health analytics for used EV marketplace
  • Full Harvest: Seed (Oct 2016) - Agricultural supply chain optimization
  • Tyba: Series A (Feb 2025) - AI-powered digital infrastructure for electrical markets
  • C.Scale: Pre-Seed (Nov 2025) - $2M investment

Stage Focus

Wireframe specializes in pre-seed and seed-stage companies:

  • Pre-seed: Early-stage founders with compelling vision, pre-revenue or pre-product
  • Seed: Teams with working products, initial customers, demonstrated product-market fit signals
  • Series A follow-ons: Selected follow-on investments for portfolio companies achieving milestones

Check sizes typically range from $500K-$2M for initial investments, with follow-on reserves at 50% of fund commitment.

Decision Process & Timeline

Wireframe operates as a partnership of equal founders with deep sector expertise. Decisions are made collaboratively between Paul Straub and Harsh Patel, with Lily Bernicker providing additional perspectives. The firm prioritizes founder relationships and typically makes decisions based on:

  1. Clear vision and articulation of the business
  2. Founder-mission alignment
  3. Large addressable market or category creation potential
  4. Ability to be hands-on support partner

Decision timeline is typically 2-4 weeks for committed partners with good founder-VC fit.

Lead Tendency & Round Structure

Wireframe leads the majority of their seed rounds and joins high-quality syndicates for pre-seed. The firm is willing to be the sole institutional investor at pre-seed if the founder story is compelling. They maintain strong co-investor relationships and typically syndicate with other mission-driven early-stage investors.

Geographic Focus

Primary focus on US markets, with headquarters in San Francisco/Bay Area (specifically Mill Valley, CA). Strong presence in:

  • San Francisco Bay Area
  • US broadly (portfolio companies nationwide)
  • Selective international investments in founders building global solutions

Founder Preferences

Wireframe explicitly seeks founders who embody:

  1. People: Driven by clear vision for extraordinary company, uniquely qualified to build it
  2. Product: Groundbreaking product that redefines existing market or creates new category
  3. Purpose: Mission to improve health of people and planet is core strategic advantage

The firm has strong track record backing:

  • First-time founders (67% of portfolio)
  • Technical founders with deep domain expertise
  • Founders from underrepresented backgrounds (38% female/URM)
  • Founders who've worked at scale (Google, AWS, etc.)
  • Founders in hard-tech, biotech, and climate (require domain knowledge)

Explicitly does NOT back:

  • Founders without genuine mission alignment
  • Pure social impact with unproven business models
  • Founders without relevant domain experience for hard-tech sectors

Warm Introduction Preference

Wireframe is willing to meet founders through warm introductions from trusted advisors, portfolio CEOs, and network members. However, the firm's website makes clear they are actively evaluating pitches and accepting business inquiries at [email protected] with a pitch form.

Typical Involvement

Wireframe provides:

  • Board seat in seed investments (occasionally observer seat)
  • Hands-on advisory: Weekly to bi-weekly check-ins post-investment
  • Operational support: Help with hiring, customer introductions, fundraising strategy
  • Domain expertise: Direct access to founders' deep sector knowledge
  • Network access: Co-investor relationships, customer/partner introductions
  • Strategy support: Product-market fit guidance, Series A positioning

Notable Co-Investors

Wireframe frequently syndicates with:

  • Foundry Group (developer tools/SaaS)
  • Khosla Ventures (climate tech)
  • First Round Capital (early-stage syndication)
  • Various strategic investors in climate, biotech, and healthcare

Recent Activity & Fund Status

Wireframe II Status: Actively deploying from $77M fund closed April 2022. Recent major follow-on: Bedrock Energy Series A (Jan 2025) at $12M (from $9M seed in Oct 2023).

2025 Activity: Continuing to deploy across themes with focus on:

  • Post-Series A follow-ons for successful companies
  • New seed investments in climate and biotech
  • Series A participation for select portfolio companies

Fund III Plans: No public announcement yet, but typical VC practice suggests potential fundraising in 2025-2026 timeframe given Fund II performance metrics.

Market Positioning

Wireframe is recognized as a top-tier mission-driven seed investor with:

  • Strong performance metrics (71% follow-on funding rate)
  • Notable exits and unicorn portfolio companies
  • Deep domain expertise in climate, biotech, and healthcare
  • Willingness to back first-time founders with compelling missions
  • Hands-on, founder-friendly approach
  • Long-term commitment to portfolio support

Competitive Positioning

Wireframe competes with:

  • Mission-driven VCs: Breakthrough Energy Ventures (climate-focused, larger checks), DBL Partners (impact)
  • Generalist seed funds: Sequoia (larger checks), Initialized (technical founders)
  • Sector-specific funds: Khosla Ventures (climate, deeper pockets), Third Rock (biotech, larger checks)

Wireframe's differentiator is the combination of:

  1. Founder-first approach with hands-on support
  2. Explicit mission-alignment requirement
  3. Willingness to back technical founders with no prior fundraising experience
  4. Equal partnership structure enabling quick decision-making
  5. Proven track record across multiple impact themes

Investment Thesis Summary

Wireframe believes that the world's most important problems require technology solutions, and the best founders solving these problems are driven by mission as much as market opportunity. By backing extraordinary founders with compelling products addressing climate, health, and biological challenges, and by providing hands-on support from seed through Series A, Wireframe accelerates the transition to a healthier, more sustainable future. The fund's exceptional follow-on funding rate (71%) demonstrates founder-VC fit and market validation of the investment thesis.

04Selected Portfolio
AgTech & Agriculture
Full Harvest·Applied Carbon
Biotech & Life Sciences
Mammoth Bio·Mycoworks·Reverie Labs·Caladan·Passkey Therapeutics·Pasture Biosciences·Think Bioscience·DNAnexus·Dinamo Biotechnologies·Enveda Biosciences
Climate & Sustainability
Cocoon Carbon·C.Scale·Bedrock Energy
E-commerce & Marketplaces
Trove
Energy & Power
Xcimer·Level Ten Energy·Span.IO·Bedrock Energy·Gridware·Sora Fuel
Enterprise Software
Near Space Labs·Astronomer·Palantir·Tembo·Salient Predictions·Terraline
Fintech & Payments
OpenInvest
Healthcare & Digital Health
Zivian Health·Endpoint Health·Arise Health·Ezra
Mobility & Transportation
Recurrent·Electriphi
Other
TYBA·Canopy Climate
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

See full activity (11) →
Participated in Dinamo Biotechnologies' seed round for AI-powered drug discovery in immunology.
INVESTMENT·tracxn.com
APR 20, 2026
Participated in Sora Fuel's $14.6M Series A to scale air-to-fuel technology.
INVESTMENT·sorafuel.com
APR 8, 2026
Participated in Cocoon Carbon's $15M Series A for sustainable construction materials.
INVESTMENT·proptechconnect.com+1
MAR 18, 2026
Participated in Ezra's $8M Seed round for AI infrastructure in asset-backed finance markets.
INVESTMENT·finance.yahoo.com
MAR 12, 2026
Portfolio company MycoWorks was acquired by DFX Corp in strategic restructuring.
EXIT·prweb.com
JAN 30, 2026
06Frequent co-investors
CV
Congruent Ventures
Both backed 3 of the same companies
Ezra, Span.IO, Applied Carbon
GC
Gigascale Capital
Both backed 3 of the same companies
Cocoon Carbon, Pasture Biosciences, Xcimer
PV
Prelude Ventures
Both backed 3 of the same companies
Trove, Recurrent, Xcimer
BC
Boom Capital
Both backed 2 of the same companies
Endpoint Health, Dinamo Biotechnologies
C
CincyTech
Both backed 2 of the same companies
Tembo, Astronomer
Find the investors for your round→
07Similar Firms
DC
Divergent Capital
$250K – $1M · Pre-Seed · Seed
→
C
Cantos
$400K – $1.5M · Pre-Seed · Seed
→
HV
Horizons Ventures
$1M – $25M · Pre-Seed · Seed
→
BV
Better Ventures
$500K – $1M · Pre-Seed · Seed
→
MR
Manta Ray
$250K – $3M · Pre-Seed · Seed
→
Quick Reference
Check Size
$500K – $2M
Stages
Pre-Seed · Seed
AUM
$77M
Decision
Partnership · ~2 Weeks
Warm Intro
Not Required
Involvement
Board Seat
Location
San Francisco, California
Sector Focus
Biotech & Life SciencesLogistics & Supply ChainRobotics & AutomationClimate & SustainabilityEnterprise SoftwareEnergy & PowerHealthcare & Digital Health
Models
Climate TechBiotechHealthcare ITClean EnergySustainable Transportation
Technology
CRISPRAI/MLSynthetic BiologyClean Energy Tech
See all Biotech & Life Sciences investors →See all Logistics & Supply Chain investors →See all Robotics & Automation investors →
Visit www.wireframevc.com ↗

See how Wireframe Ventures matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Biotech & Life SciencesLogistics & Supply ChainRobotics & AutomationClimate & SustainabilityEnterprise SoftwareEnergy & PowerHealthcare & Digital Health

See how Wireframe Ventures matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched July 28, 2026F4 Research Engine